Skip to main content
. 2007 Mar;12(1):44–50. doi: 10.1379/CSC-229R.1

Fig 5.

Fig 5.

Immunolocalization of cleaved-caspase-3 on whole-mount embryos. Embryos treated with 1 mM CdCl2, respectively, at blastula (A–C) and gastrula (E–G) stages for 15, 21, and 24 hours, incubated with anti-cleaved-caspase-3 antibody. Control embryos (34 and 44 hours of development, respectively) incubated with anti-cleaved-caspase-3 (D, H)